CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.06B
This Quarter Return
-0.32%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
10 Year Return
AUM
$238M
AUM Growth
+$238M
Cap. Flow
+$26.9M
Cap. Flow %
11.34%
Top 10 Hldgs %
35.07%
Holding
478
New
384
Increased
35
Reduced
29
Closed
12

Top Sells

1
ZTO icon
ZTO Express
ZTO
$5.15M
2
JD icon
JD.com
JD
$4.92M
3
EDU icon
New Oriental
EDU
$4.58M
4
LI icon
Li Auto
LI
$4.43M
5
NTES icon
NetEase
NTES
$3.29M

Sector Composition

1 Technology 36.45%
2 Consumer Discretionary 23.79%
3 Healthcare 23.76%
4 Communication Services 3.6%
5 Consumer Staples 3.15%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
IMGO
276
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$5K ﹤0.01%
+316
New +$5K
BLUE
277
DELISTED
bluebird bio
BLUE
$5K ﹤0.01%
+722
New +$5K
CGEM icon
278
Cullinan Oncology
CGEM
$442M
$5K ﹤0.01%
+427
New +$5K
COLL icon
279
Collegium Pharmaceutical
COLL
$1.23B
$5K ﹤0.01%
+320
New +$5K
EWTX icon
280
Edgewise Therapeutics
EWTX
$1.57B
$5K ﹤0.01%
+467
New +$5K
IDYA icon
281
IDEAYA Biosciences
IDYA
$2.23B
$5K ﹤0.01%
+368
New +$5K
IPSC icon
282
Century Therapeutics
IPSC
$41.1M
$5K ﹤0.01%
+551
New +$5K
GTHX
283
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$5K ﹤0.01%
+401
New +$5K
ABOS icon
284
Acumen Pharmaceuticals
ABOS
$82.4M
$4K ﹤0.01%
+379
New +$4K
CDXS icon
285
Codexis
CDXS
$227M
$4K ﹤0.01%
+613
New +$4K
EOLS icon
286
Evolus
EOLS
$485M
$4K ﹤0.01%
+525
New +$4K
ESPR icon
287
Esperion Therapeutics
ESPR
$468M
$4K ﹤0.01%
+623
New +$4K
EXAS icon
288
Exact Sciences
EXAS
$9.09B
$4K ﹤0.01%
128
FULC icon
289
Fulcrum Therapeutics
FULC
$347M
$4K ﹤0.01%
+487
New +$4K
GLUE icon
290
Monte Rosa Therapeutics
GLUE
$304M
$4K ﹤0.01%
+437
New +$4K
IMRX icon
291
Immuneering
IMRX
$255M
$4K ﹤0.01%
+247
New +$4K
INO icon
292
Inovio Pharmaceuticals
INO
$137M
$4K ﹤0.01%
+2,336
New +$4K
KNSA icon
293
Kiniksa Pharmaceuticals
KNSA
$2.54B
$4K ﹤0.01%
+323
New +$4K
KOD icon
294
Kodiak Sciences
KOD
$455M
$4K ﹤0.01%
+487
New +$4K
KPTI icon
295
Karyopharm Therapeutics
KPTI
$58.8M
$4K ﹤0.01%
+747
New +$4K
PHAT icon
296
Phathom Pharmaceuticals
PHAT
$841M
$4K ﹤0.01%
+367
New +$4K
PTGX icon
297
Protagonist Therapeutics
PTGX
$3.66B
$4K ﹤0.01%
+460
New +$4K
RLYB icon
298
Rallybio
RLYB
$23.3M
$4K ﹤0.01%
+301
New +$4K
SEER icon
299
Seer Inc
SEER
$115M
$4K ﹤0.01%
+548
New +$4K
TGT icon
300
Target
TGT
$42B
$4K ﹤0.01%
+29
New +$4K